Investigational Site Number :7240001

Madrid, Madrid, Comunidad de 28046

0 studies enrolling now · 5 studies all time

What they study most

Breast Cancer, Chronic Spontaneous Urticaria, Gastric Cancer, Hemophilia A, Lung Neoplasm Malignant, Neoplasm, Neoplasm Malignant

Studies at this site

• Long-term Safety and Efficacy of Efanesoctocog Alfa (BIVV001) in Previously Treated Patients With Hemophilia A — Running, not enrolling
• Dose Escalation and Expansion Study of SAR443216 in Participants With Relapsed/Refractory HER2 Expressing Solid Tumors — Stopped early
• Safety, Efficacy and PK of BIVV001 in Pediatric Patients With Hemophilia A — Completed
• Dupilumab for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 Antihistamine and Who Are naïve to, Intolerant of, or Incomplete Responders to Omalizumab (LIBERTY-CSU CUPID) — Completed
• Effect of Tusamitamab Ravtansine on QTc Interval in Participants With Metastatic Solid Tumors — Stopped early